Cutaneous Melanoma Detection and ManagementNonmelanoma Skin Cancer StudiesMelanoma and MAPK Pathways

Sarab Jeet Singh, Charan Jeet Arora, A. Khan, James Y. Mitchell, Irfanullah Irfanullah, P. Kour

2026.3.31Journal of Pakistan Association of Dermatologists

DOI: 10.66344/jpad.v36i1.3200

Abstract

Acral melanoma is a rare subtype of cutaneous melanoma that often presents late in resource-limited settings. We report a 67-year-old woman from District Swat, Pakistan, with a 5-year history of a neglected pigmented plantar lesion who presented with jaundice and weight loss. CT imaging showed a large para-aortic retroperitoneal mass causing hydronephrosis and periampullary compression with biliary dilatation, along with liver metastases. Trucut biopsy revealed metastatic melanoma (S100+, HMB-45+, SOX10+). Molecular testing for BRAF V600 mutation was recommended but not performed due to unaffordability. Nivolumab monotherapy (anti–programmed cell death protein 1 [anti–PD-1]) was started, as dual immune checkpoint blockade was unaffordable, and a ureteric stent was placed. The patient was subsequently lost to follow-up. This case highlights diagnostic complexity and therapeutic inequities in metastatic acral melanoma in a resource-limited setting.

Citation format

SINGH, Sarab Jeet, et al. Metastatic acral melanoma with retroperitoneal and liver metastases: Diagnostic challenges and therapeutic dilemmas in a resource-limited clinical setting of district swat, pakistan. Journal of Pakistan Association of Dermatologists, 2026, 36(1): 132–135.